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Abstract
Background: In the United Kingdom, the thermophilic Campylobacter species C. jejuni and C. coli are the most
frequent causes of food-borne gastroenteritis in humans. While campylobacteriosis is usually a relatively mild
infection, it has a significant public health and economic impact, and possible complications include reactive
arthritis and the autoimmune diseases Guillain-Barré syndrome. The rapid developments in “omics” technologies
have resulted in the availability of diverse datasets allowing predictions of metabolism and physiology of
pathogenic micro-organisms. When combined, these datasets may allow for the identification of potential
weaknesses that can be used for development of new antimicrobials to reduce or eliminate C. jejuni and C. coli
from the food chain.
Results: A metabolic model of C. jejuni was constructed using the annotation of the NCTC 11168 genome
sequence, a published model of the related bacterium Helicobacter pylori, and extensive literature mining. Using
this model, we have used in silico Flux Balance Analysis (FBA) to determine key metabolic routes that are essential
for generating energy and biomass, thus creating a list of genes potentially essential for growth under laboratory
conditions. To complement this in silico approach, candidate essential genes have been determined using a whole
genome transposon mutagenesis method. FBA and transposon mutagenesis (both this study and a published
study) predict a similar number of essential genes (around 200). The analysis of the intersection between the three
approaches highlights the shikimate pathway where genes are predicted to be essential by one or more method,
and tend to be network hubs, based on a previously published Campylobacter protein-protein interaction network,
and could therefore be targets for novel antimicrobial therapy.
Conclusions: We have constructed the first curated metabolic model for the food-borne pathogen Campylobacter
jejuni and have presented the resulting metabolic insights. We have shown that the combination of in silico and in
vivo approaches could point to non-redundant, indispensable genes associated with the well characterised
shikimate pathway, and also genes of unknown function specific to C. jejuni, which are all potential novel
Campylobacter intervention targets.
Background
The rise of antibiotic resistance in pathogenic bacteria is
a growing concern in the developed world necessitating
knowledge-led approaches to identify new interventions
and prevention strategies [1]. One of the common
sources of pathogenic bacteria is food, with the food-
borne zoonotic pathogens Salmonella, Escherichia coli
and Campylobacter being prime examples. Although it
can be contended whether the use of antibiotics in the
food industry contributes to antimicrobial resistance, it
is clear that food-borne pathogens also increasingly
acquire resistance to antimicrobial interventions. Multi-
drug resistance in Salmonella is well documented [2,3].
For Listeria, antibiotic resistance has also been reported
for strains isolated from food [4]. In Campylobacter,
resistance to ampicillin, erythromycin, tetracycline, and
ciprofloxacin have all been reported [5-7].
In Europe, Campylobacter was the most frequent
cause of food-borne illness in 2007, with over 200,000
laboratory-confirmed cases [8] although the total num-
ber of cases is thought to be approximately eightfold
higher. Infection by Campylobacter is thought to be lar-
gely due to the consumption of contaminated poultry
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cooking [9]. While the symptoms associated with C.
jejuni infection (diarrhoea, vomiting, and stomach pains)
often only last between 2 to 5 days, sequelae of C. jejuni
infection include more serious autoimmune diseases like
Guillain-Barré syndrome, Miller-Fisher syndrome [9],
and reactive arthritis [10]. While human infection often
does not require antibiotic intervention, the organism is
endemic in poultry and farm animals, and it would be
advantageous to have treatment options before entry in
the food chain.
One approach for the identification of new antibiotic
targets for a particular bacterial pathogen is to identify
non-redundant cellular functions or metabolic pathways
that are indispensible for growth and/or survival of that
organism; for example, key metabolic enzymes or cell
wall synthesis proteins. In the post-genomic era, genome
analysis makes both bioinformatic predictions and tar-
geted mutagenesis strategies feasible, due to the avail-
ability of large, curated datasets. However, genome
annotation is often incomplete and incorrect, and meta-
bolic redundancy (alternative pathways or catalytic activ-
ities) can confound such rational approaches. For
instance, a comprehensive study in Salmonella of essen-
tial genes required during infection showed that many
enzymes are not essential, partly due to metabolic
redundancy [11]. An alternative (experimental, high-
throughput) strategy is the use of random approaches
such as transposon mutagenesis to identify essential
genes that would be needed to infect an animal model
or to grow and proliferate [12-14].
In silico, essential genes of well characterised micro-
organisms, such as E. coli, are predicted with high accu-
racy by Flux Balance Analysis (FBA) of the metabolic
network [15]. FBA consists of the computation of the
fluxes going through the metabolic reactions when the
cells are in a homeostatic state [15]. The reactions are
linked to the genes that encode the corresponding
enzymes with Boolean relationships, and, a gene is pre-
dicted to be essential if in silico deletion results in negli-
gible biomass [15]. According to Feist et al., [16], about
90% of essential genes of E. coli can be predicted in a
given environment. For micro-organisms other than the
established model systems, the accuracy is lower (60-
80%) [17,18]. Nevertheless, it provides insights into cel-
lular metabolism, which can be useful to identify poten-
tial new drug targets [19].
In this study we have constructed a genome scale
metabolic model of the food-borne pathogen Campylo-
bacter jejuni and discuss this organism’s metabolism.
Additionally, we have combined both in silico and in
vivo approaches to make predictions about essential
genes. A published FBA model of the closely related
organism Helicobacter pylori [18] provided the basis for
a Campylobacter FBA model. The essential genes pre-
dicted from FBA of the reconstructed genome scale
model of C. jejuni were compared to new experimen-
tally generated transposon mutagenesis data, and a
recently published independent whole genome transpo-
son mutagenesis study [20]. Whilst the overlap between
the three methods is comparatively small, the combina-
tion of these methods has drawn focus to the shikimate
pathway, a known target pathway for new antimicrobial
interventions in other bacterial pathogens [21].
Results
Metabolic network reconstruction
In a first step, we have reconstructed the metabolic net-
work of C. jejuni based on the annotation of the NCTC
11168 genome sequence [22,23], a published model of
the related bacterium H. pylori [18] and extensive litera-
ture mining. The resulting network is made of 536 reac-
tions in total accounting for 388 genes and 467
metabolites, that is, it is of similar size as the model of
H. pylori (see Table 1 for the number of reactions in
this model as compared with the H. pylori model and
the Additional file 1: model for a table with the model
itself). In this section we will discuss specific areas of C.
jejuni metabolism as present in, or predicted by, our
model.
Central metabolism
The reactions of the central metabolism have been
mainly drawn from the literature since contrarily to H.
pylori, C. jejuni is predicted to contain a complete TCA
cycle with some enzymes characteristic for anaerobes
[24]. C. jejuni does not metabolise glucose [25] and the
genome annotation suggests that the Embden-Meyerhof
pathway only functions in gluconeogenesis [24], so over-
all the space of solution of fluxes is different from H.
pylori. The respiratory chain of C. jejuni is more com-
plex than that of H. pylori [26], and C. jejuni can use
sulphite as an electron donor [27].
The biosynthesis of folate results in the production of
glycolaldehyde, which can cause cell damage by electro-
philic attack of negatively-charged molecules [28]. In the
H. pylori and E. coli models, glycolaldehyde is converted
to glycolate by a glycolaldehyde dehydrogenase and
Table 1 Number of reactions in the C. jejuni model (this
paper) and in the H. pylori model [18].
Type of reaction C. jejuni model H. pylori model
Metabolic 410 (367) 399 (317)
Transport 64 (32) 77 (38)
Sink/demands 3 3
Exchange 59 74
Total 536 553
The number of reactions associated to genes is given in brackets.
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lism [16,18]. Alternatively glycolate can diffuse out of
the cell in the case of E. coli [16]. Since a glyoxylate oxi-
dase (Cj1213c) has been annotated [23] and since glyox-
ylate has been shown to be degraded via a malate
synthase in H. pylori [29], we assumed a malate synthase
in our model despite the genome lacking the corre-
sponding annotation as in H. pylori [30,31].
Amino acid metabolism
The reactions for the amino acid metabolism have been
mainly drawn from the genome annotation. Contrarily
to H. pylori, C. jejuni seems to have the capacity to
synthesize all the amino acids and vitamins it requires.
This was shown experimentally with BIOLOG pheno-
type microarrays, where respiration was detected on
growth medium containing salts and a carbon source
only [32]. From the genome sequence, complete path-
ways for the synthesis of isoleucine, leucine and valine,
are present in C. jejuni, whereas these pathways are
incomplete or absent in H. pylori. In addition to the
amino acids required by H. pylori, a complete pathway
to synthesize histidine was found in C. jejuni (cj0317,
cj1315c, cj1597-99, cj1600-01, cj1603-04) while orthologs
of these genes are absent in the H. pylori genome. The
gene for the last step of methionine synthesis is pre-
dicted to be present in C. jejuni (cj1201), so no demand
reaction was included in the model to artificially con-
sume S-adenosylmethione. In common with H. pylori,
only one gene of the methionine salvage pathway was
found to be present in C. jejuni (cj0117). In the iIT341
GSM/GPR H. pylori model, the pathway was neverthe-
less included to ensure the recycling of 5-methylthioade-
nosine, a by-product of spermidine biosynthesis, to
methionine, based on the assumption that the pathways
vary from one micro-organism to another. However it
has recently been suggested that the last steps of sper-
midine biosynthesis in C. jejuni differ from the pathway
proposed for H. pylori [33] eliminating the necessity for
recycling 5-methylthioadenosine, so the methionine sal-
vage pathway was not included in this model.
Nucleotide metabolism
The reactions for the nucleotide metabolism have been
almost exclusively derived from the genome annota-
tion. The pathway for the synthesis of IMP is more
similar to that of E. coli, rather than that of H. pylori.
O n l yaf e wg e n e sh a v eb e e na n n o t a t e da tt h el e v e lo f
nucleotide inter-conversions such as cj0293 which has
been predicted to encode for a nucleotidase [23]. How-
ever most of the products of the reactions catalysed by
this enzyme are not reutilised in the metabolic net-
work, they are dead-ends. So either cj0293 is incor-
rectly annotated, or genes encoding enzymes to utilize
the products of the nucleotidase have not been
annotated.
Vitamin and cofactor metabolism
In the H. pylori model iIT341 GSM/GPR, it was
assumed that pimelate diffuses into the cell and that the
first step of the synthesis of biotin is catalysed by pime-
lyl-CoA synthetase although no locus was found for
such a gene [18]. Having no better alternative, we kept
the assumption of the H. pylori model. C. jejuni does
not contain ubiquinone, but uses menaquinone 6 and a
methyl-substituted menaquinone [34]. It has been
shown that for Streptomyces coelicolor, H. pylori, C.
jejuni and Thermus thermophilus,t h ep a t h w a yf o r
menaquinone synthesis diverges from the one from E.
coli with futalosine as an intermediate [35]. However the
pathway is not completely elucidated so in this model,
the equations of the pathway of E. coli were kept as in
the model iIT341 GSM/GPR. As for the ubiquinone, the
same three gene orthologs of the genes present in H.
pylori have been predicted to be present in C. jejuni.
Thiamine is essential for the growth of some strains of
Campylobacter [36] but not for the strain NCTC11168
[32]. According to the genome annotation, the pathway
for its synthesis is complete.
Cell wall metabolism
There is little evidence about the composition of the cell
wall of C. jejuni in the literature, and the genome anno-
tation suggests that the pathways are neither those of E.
coli nor those of H. pylori. For instance, only 2 genes
are annotated as part of the fucose biosynthesis pathway
in C. jejuni (cj1407c and cj1428c), while 6 such genes
are annotated in H. pylori. However in the absence of
better data, the pathways for the cell wall metabolism
were copied from the model iIT341 GSM/GPR. It has
been shown that the fatty acid composition of C. jejuni
changes with the environmental conditions and/or the
growth rate [37,38] but the predominant fatty acid have
been reported to be the saturated hexadecanoic acid, the
unsaturated octodec-1l-enoic acid and to a lesser extent
cyclopropane in C19 and tetradecanoic acid which
increased with stress [37-40]. These are the same fatty
acids that are included in the model iIT341 GSM/GPR.
Other
It is not clear from the genome sequence nor from the
literature how C. jejuni assimilates sulphur, and hence
we have used the assumptions used for H. pylori [18].
Transport reactions were mainly drawn from circum-
stantial evidence. Three “sink reactions” were added to
the model because the pathways for the degradation of
the corresponding products are unknown, and the ones
used are the same as the ones introduced in E. coli [16]
and H. pylori [18].
Exploration of the predicted metabolism of C. jejuni
To test the model, the production of biomass from dif-
ferent carbon sources was simulated and the results are
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lisation. Out of the 19 substrates tested, three are not
included in the model (bromosuccinate, methyl pyru-
vate, a-hydroxybutyrate) and for four of them, it is not
clear from the literature whether they can be used as a
sole carbon source or not. According to the model, glu-
tamate, citrate, a-ketoglutarate, aspartate, asparagine, L-
lactate, L and D-malate, succinate, fumarate, pyruvate
and serine can be metabolised in agreement with the
data of the literature. The model also allowed the meta-
bolism of proline and L-glutamine, which did not pro-
duce significant respiration with the BIOLOG
experiments [32], however they were metabolised once
aspartate and serine were depleted, alongside other che-
micals in the defined media [37]. It is not clear whether
formate can be used as an electron donor only [41] or a
c a r b o ns o u r c ea sw e l l[ 4 2 , 4 3 ] ,b u tc a n n o tb eu s e da sa
sole carbon source according to the microarray experi-
ments [32] and is not predicted to be metabolised in the
model. Cysteine has been shown to be metabolised
[37,42] but was not predicted to be sufficient as a sole
carbon source. Finally, no regulatory constraint was con-
sidered in any of the simulations, the only constraints
used were the rate of consumption of the carbon source
and oxygen source.
In silico prediction and experimental identification of
essential genes in C. Jejuni
The metabolic model in combination with FBA was
used to predict the metabolic genes that are essential
for the production of biomass in rich medium (see
Materials and Methods). This generated a list of 176
predicted essential genes (see Additional file 3: predic-
tions of essential genes).
Whilst the use of FBA to predict essential genes has
been shown to be effective [16], it only focuses on those
genes encoding proteins in the metabolic model. To
make a genome-wide assessment of gene essentiality, we
used random in vitro transposition using two transposon
inserts to generate two transposon libraries in C. jejuni
11168 (see Materials and Methods). The Mariner and
Tn7 transposon libraries contained 7381 and 2169
unique inserts, respectively. Using a PCR-based genomic
insertion site mapping strategy with validated primers
for each annotated ORF in the C. jejuni genome
sequence, the insertion site of each transposon was
mapped as shown in Figure 1 with an accuracy of +/-
50 nt. Table 2 shows a summary of the results of the
genome-wide transposon mutagenesis experiments. In
total, 233 genes were identified as lacking either Tn7 or
Mariner insert, and therefore potentially essential under
the growth conditions used in this study. A more
detailed list of insert locations is available as the Addi-
tional file 3: predictions of essential genes including the
47 directed mutants, and a summary of the proteins
encoded by genes without a transposon insert, classified
according to the KEGG, BioCyc, and JCVI databases, is
shown in Additional file 4: genes without inserts by
pathway. Such an analysis shows the predominance of
essential genes associated with: aromatic amino acid
metabolism, tRNA metabolism and protein synthesis,
energy transduction/TCA cycle, the cell envelope, and
purine and pyrimidine metabolism. There are also 27
genes (≈10% of the total in the annotated genome) with
no inserts encoding hypothetical proteins of unknown
function. Fifteen of these hypothetical proteins do not
have homologs outside the Epsilon sub-division of the
Proteobacteria and tend to be small proteins (median
s i z e ,5 . 6k D a ,m i ns i z e ,3 . 6k D a ;m a xs i z e ,2 6 . 4k D a ) .A
further subset of four genes are specific to the jejuni
species of Campylobacter (cj0416, cj0747-8,a n dcj0974)
and potentially encode small polypeptides (median size,
3.8 kDa, min size, 3.6 kDa; max size, 5.4 kDa). The
cj0416 and cj0747-8 genes are subject to regulation as
significant changes in transcription of these genes have
been reported in microarray studies [44-47]. Thus far,
no published proteomic studies in C. jejuni have identi-
fied these proteins, although their small size may have
hampered detection in previous studies. Analysis of
these small proteins with respect to the published pro-
tein-protein interaction network [48] shows that, with
the exception of cj0344 (not present in the study), these
proteins tend to be hubs, interacting with a large num-
ber of other proteins. For instance, interactions between
cj0748 and 115 other proteins (including cj0974)a r e
detected in the published network.
The two lists of predicted essential genes, one result-
ing from FBA, and other from global in vitro transposi-
tion, were compared to assess both the intersection and
differences. A comparison of these lists shows an inter-
section of 42 genes (Table 3). Assuming that the in vitro
transposition is not biased, the model would achieve
60% accuracy (percentage of the total number of genes
predicted to be essential or non essential by both meth-
ods). Figure 2 shows the distribution of the number of
genes predicted to be essential or dispensable as pre-
dicted by FBA (in silico) and measured by the number
of insert (in vivo) by metabolic pathway. Some of the
genes predicted to be essential by FBA belonged to cen-
tral metabolism, especially the gluconeogenesis pathway.
Specifically, each step from phosphoenol-pyruvate to
glucose-6-phosphate is predicted to be essential by FBA.
However, the transposon mutagenesis only identified 3
genes involved in gluconeogenesis: cj1403c (glyceralde-
hyde 3-phosphate dehydrogenase), cj0597 (fructose-
bisphosphate aldolase), and cj0840c (fructose-1,6-bispho-
sphatase). Nine of the 23 genes predicted to be dispen-
sable by FBA that did not contain transposons, encode
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cj1153, cj1490c, cj1566c, cj1567c, cj1569c, cj1571c and
cj1572c), confirming that the respiration chain of C.
jejuni, whilst being essential for viability, is complex and
not fully understood [26]. Concerning the vitamins and
cofactors, predictions by FBA are uncertain because
only verified transport reactions were included in the
FBA model. In addition, the range of chemicals allowed
in the medium for the FBA simulation was conservative
because the medium composition is not well defined.
This might explain the discrepancies for the biosynthesis
of biotin, folic acid and pantothenate where most of the
genes associated with the pathways were predicted to be
essential by FBA, but were not essential according to
the transposon mutagenesis. Riboflavin was assumed to
be present in the medium and used by the cell [49] so it
was predicted non-essential by FBA in agreement with
our transposon mutagenesis data. In the transposon
study of Stahl and Stintzi [20], they proposed that ribo-
flavin biosynthesis is an essential pathway, perhaps
because they used a different medium. Although ubiqui-
none has not been isolated from C. jejuni [34], the gen-
ome is predicted to encode three proteins that
participate in ubiquinone biosynthesis [23]. Cj0324
could be attributed to the synthesis of menaquinone but
cj0546 (UbiD) did not have any transposon inserts
Table 2 Summary of the genome wide transposon
mutagenesis for C. jejuni
Transposon library Tn7 Mariner Combined
Number of inserts measured 2251 7654 9905
Number of inserts in genes 2169 7380 9549
Percentage of inserts within genes 96.35 96.42 96.40
Number of genes with 1 or more inserts 1029 1240 1421
Number of genes with no insert 625 414 233
pseI      maf1     cj1319   cj1320    cj1321   cj1322   cj1323   cj1324   cj1325    neuB2    neuC2   cj1329    cj1330    ptmB      ptmA     pseD       maf3      maf4      pseE             
cj0889c  cj0890c   serA     cj0892c     rpsA      ispH       aroA       pheT       pheS     cj0898           thiJ      cj0900c   cj0901    glnQ 
cj0501       hemH   cj0504c cj0505c       alaS        maf       pbpA            clpB   cj0510c    cj0511 
Putative Non-essential gene 
 
Putative Essential gene 
 
Mariner transposon insert site 
 
Tn7 transposon insert site 
 
Pseudogene showing stop codons 
 
Polymorphism (G/C)n 
cj
Figure 1 Circular representation of the C. jejuni NCTC11168 genome showing positions of transposon inserts.O u t e r2c i r c l e s :o p e n
reading frames (purple) and pseudogenes (black) on the forward and reverse DNA strands. The next two circles show insert positions based on
the Mariner library (dark red) and the Tn5 library (light red). The innermost circle shows %GC. Numbers on the outermost circle show the base
number with respect to the start of dnaA (cj0001). Box outs show examples of the transposon mutagenesis analysis (genes are not drawn to
scale). Genes are predicted essential if they lack any transposon insert (e.g. alaS or aroA) while genes with an insert are predicted to be
dispensable for growth under laboratory conditions. The upper box out shows a region of the genome densely populated by transposon inserts
and therefore this whole region is likely dispensable for growth under laboratory conditions. This region of the chromosome encodes functions
relating to cell envelope biosynthesis and flagella modification.
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function.
One important caveat of the essential gene predictions
using FBA is that some pathways were copied from H.
pylori. In addition many genes annotated to be part of
the cell wall were not taken into account in the model.
However many genes involved in fatty acid metabolism
and all the genes involved in fatty acid elongation are
predicted to be essential by FBA: cj0328c (FabH), cj1303
(FabH2), cj0442 (FabF), cj0435 (FabG), cj0273 (FabZ),
and cj1400c (FabI). FabD (cj0116) and FabF are also pre-
dicted essential from the transposon study. Fatty acid
biosynthesis in Campylobacter is likely to contribute to
the biosynthesis of the cell envelope, so it is perhaps not
surprising that this is a key pathway.
Comparison of the essential gene predictions with a
published study
The predictions made in this study were further com-
pared to the published transposon mutagenesis study of
Stahl and Stintzi [20]. The greatest overlap is between
FBA and our transposon list (35 genes) as illustrated in
Figure 3 and listed in Table 3. There are only 26 genes
that overlap between our transposon study and the pub-
lished study of Stahl and Stintzi [20]. Eight genes are
common to all three lists although they encode proteins
from a number of disparate pathways (cj0231c (NrdF),
cj0545 (HemC), cj0707 (KdtA), cj0810 (NadE), cj0855
(FolD), cj0895c (AroA), cj1644 (IspA), cj1676 (MurB)).
An analysis of the intersection genes, with respect to the
KEGG, JCVI, and BioCyc databases, shows clusters of
genes associated with: purine and pyrimidine metabo-
lism, the cell envelope, cofactor biosynthesis (menaqui-
none/ubiquinone, folic acid, biotin, heme), and a cluster
of five hypothetical proteins with no known function
(cj0364, cj0703, cj0711, cj0939c,a n dcj1712). Following
further analysis of these protein sequences using BLAST
and the Pfam database, cj1712 is revealed to be a puta-
tive PunB/DeoD homolog (purine nucleoside phosphor-
ylase) involved in purine and pyrimidine metabolism as
shown by the amino acid sequence containing a Phos-
phorylase superfamily domain (E = 1.3e-07) and show-
ing between 40-80% identity to other proteins annotated
as PunB/purine nucleoside phosphorylases in the NCBI
microbial database. Three genes from the aromatic
amino acid biosynthetic pathway (specifically, the shiki-
mate pathway) are also present in the intersection list.
Further analysis of this pathway, shows that nine genes
encoding proteins from this pathway are predicted to be
essential by one or more of the techniques used in this
study (Figure 4). Furthermore, analysis of these proteins
with respect to the published protein-protein interaction
network [48] reveals that many proteins from this path-
way have a high number of interactions with other pro-
teins and may therefore be classified as ‘hubs’ in the
metabolic network (Figure 4). Interestingly, a number of
these genes are also subject to transcriptional regulation
in a virulence model [46]. Taken together, these data
point to biosynthesis of aromatic amino acids as a
potential metabolic weak-point in Campylobacter, which
is also relevant during infection.
Discussion
I nt h i ss t u d yw eh a v ec o m b i n e db i o i n f o r m a t i c
approaches to construct and validate a genome-wide
model of metabolism of Campylobacter jejuni,t h ef i r s t
such model of this important food-borne pathogen. Flux
Balance Analysis has been used to predict those proteins
that, if removed from the model, result in loss of bio-
mass production. To complement this in silico
Table 3 List of essential “metabolic genes” according to the different techniques
Technique Essential genes
FBA only cj0024, cj0026c, cj0066c, cj0075c, cj0127c, cj0146c, cj0172c, cj0187c, cj0194, cj0196c, cj0197c, cj0205, cj0227, cj0237,
cj0240c, cj0273, cj0274, cj0286c, cj0288c, cj0296c, cj0297c, cj0298c, cj0306c, cj0307, cj0321, cj0326, cj0332c, cj0360,
cj0384c, cj0405, cj0432c, cj0433c, cj0434, cj0435, cj0437, cj0443, cj0453, cj0490, cj0541, cj0542, cj0559, cj0576,
cj0580c, cj0585, cj0589, cj0638c, cj0647, cj0699c, cj0716, cj0764c, cj0766c, cj0767c, cj0795c, cj0798c, cj0806, cj0813,
cj0821, cj0822, cj0847, cj0853c, cj0858c, cj0862c, cj0891c, cj0905c, cj0918c, cj0932c, cj0947c, cj0949c, cj0955c,
cj0992c, cj0995c, cj1039, cj1044c, cj1046c, cj1048c, cj1067, cj1080c, cj1081c, cj1088c, cj1096c, cj1104, cj1114c,
cj1133, cj1149c, cj1150c, cj1151c, cj1152c, cj1177c, cj1183c, cj1196c, cj1198, cj1202, cj1213c, cj1238, cj1243, cj1248,
cj1364c, cj1398, cj1400c, cj1401c, cj1402c, cj1404, cj1407c, cj1424c, cj1428c, cj1476c, cj1498c, cj1515c, cj1529c,
cj1530, cj1605c, cj1634c, cj1641, cj1645, cj1672c, cj1685c
FBA & transposon mutagenesis of
this study
cj0027, cj0116, cj0117, cj0324, cj0387, cj0394c, cj0442, cj0514, cj0516, cj0581, cj0597, cj0639c, cj0641, cj0686,
cj0840c, cj0894c, cj0927, cj1008c, cj1045c, cj1054c, cj1058c, cj1082c, cj1131c, cj1250, cj1274c, cj1288c, cj1346c,
cj1347c, cj1366c, cj1403c, cj1443c, cj1536c, cj1607, cj1610, cj1652c
FBA & transposon mutagenesis of
Stahl and Stintzi
cj0132, cj0147c, cj0308c, cj0356c, cj0451, cj0503c, cj0722c, cj0845c, cj0861c, cj0925, cj1201, cj1239, cj1290c, cj1291c,
cj1531, cj1535c
FBA & the 2 transposon mutagenesis
methods
cj0231c, cj0545, cj0707, cj0810, cj0855, cj0895c, cj1644, cj1676
The “metabolic genes” refer to the genes that were included in the FBA model. This table gives the list of the genes shown in Figure 3. The genes predicted to
be essential by transposon mutagenesis were those with no insert in the transposon mutagenesis in this study and in the study of Stahl and Stintzi [20].
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Page 6 of 14predictive approach, we have used random transposon
mutagensis coupled to gene-specific PCR to identify
those genes that contain one or more transposon insert
(dispensable genes for growth under laboratory condi-
tions) and those genes that do not contain a transposon
insert, the putative essential genes.
In silico determination of essential genes
Although the reconstruction of the metabolic network
of C. jejuni is based on limited biochemical data, it was
possible to formulate a hypothesis on the metabolism of
this pathogen. The reconstruction pointed out the main
areas of uncertainty: the cell wall metabolism and
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Figure 2 Metabolic genes predicted to be essential or dispensable in silico and in vivo by pathway. The genes predicted to be essential
or non essential were determined by FBA (in silico) and from the number of inserts in a transposon mutagenesis of this study (in vivo)i n
laboratory conditions. Only the genes included in the model reconstruction for FBA are indicated. a) The pie chart shows the distribution of
genes belonging to different types of pathway in each category. b) The table indicates the total numbers of genes that fall in each category.
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Page 7 of 14nucleotide pathways. It was also found that the pathway
for sulphur assimilation is not obvious from the genome
annotation.
A malate synthase activity was an assumption in our
model, and this activity has been demonstrated in H.
pylori [29]. Based on the annotation, the genome does
not encode a malate synthase, and extensive BLAST
searching using both the malate synthase A (aceB)a n d
malate synthase G (glcB) sequences did not reveal any
match in the H. pylori or C. jejuni genomes or any gen-
ome from the epsilon sub-division of Proteobacteria. A
new class of malate synthase enzymes may be present in
H. pylori and possibly in this clade of life, that does not
have sequence homology to known characterised malate
synthase enzymes from other bacteria, although this
requires further biochemical evidence. The reconstruc-
tion of the model was mainly based on conventional
genome annotation employing BLAST searches. More
sophisticated annotation methods have been proposed
to address functional divergence amongst proteins that
share sequence similarity [50,51]. For instance, we com-
pared the EC numbers obtained with the EFICAz [52]
and PRIAM [53] tools to the EC numbers of the reac-
tions linked to a unique gene in our model (287 reac-
tions) and found discrepancies for 30 and 27 reactions
respectively. Based on the original genome annotation,
some enzymes in our model could catalyse diverse reac-
tions, while the more sophisticated annotation tools
FBA 
In vitro 
transposition 
Stahl and 
Stintzi (in vitro 
transposition) 
165  26  143 
116 
35  16 
8 
Figure 3 Genes predicted to be essential by FBA and by two independent transposon mutageneses. The essential genes determined by
FBA include “metabolic genes” only, shown in green. The “non-metabolic genes” are indicated in red. The genes predicted to be essential by
transposon mutagenesis were those with no insert in the transposon mutagenesis in this study and in the study of Stahl and Stintzi [20].
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Page 8 of 14suggested more metabolic specificity. An example is
cj0324, originally annotated as a ubiquinone/menaqui-
none methyltransferase (EC 2.1.1.-) [23], the PRIAM
tool [53] suggests specifically demethylmenaquinone
methyltransferase activity (EC 2.1.1.163), which is more
likely as menaquinone and a methyl substituted
menaquinone have been isolated in C. jejuni rather than
ubiquinone [34]. We also checked our metabolic model
against the ‘expert community’ subsystem annotation
presented in The SEED [54], which returned discrepan-
cies for 20 of the reactions considered above. For some
genes, the precise annotation depends on the method
Figure 4 The shikimate pathway. The pathway shows the biosynthesis of aromatic amino acids, via shikimate, as suggested by the genome
annotation. Each step is annotated to show the following: the enzyme (’Cj’ number and gene symbol), the prediction of essentiality based on
FBA and transposon mutagenesis, the number of interactions in the PPI network, and the direction of expression from microarray data from a
piglet model of infection. Predicted essential steps are shown in bold.
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Page 9 of 14used: returning to our glycolate to glyoxylate intercon-
version hypothesis, Cj1213c is a putative glycolate oxi-
dase subunit D (EC 1.1.3.15) [23,55], or an
alkylglycerone-phosphate synthase (EC 2.5.1.26) [52], or
a D-lactate dehydrogenase (EC 1.1.2.4) [53] making the
degradation of glycolate into glyoxylate an uncertain
assumption.
An inherent limitation of the FBA method is the suit-
ability of the objective function [56]. For instance, by
optimising the biomass, FBA does not take into account
the microaerophilic and capnophilic properties of C.
jejuni. These may indeed constitute additional con-
straints like a maximum concentration of oxygen-sensi-
tive enzymes neglected in these simulations except as
modelled by the limiting uptake rate of oxygen. Alterna-
tively, trade-off functions may be more appropriate
objective function than the optimisation of the biomass
with these kind of micro-organisms [57].
The FBA method has the potential of being condition
specific to determine the essential genes. In this study,
they were determined in laboratory conditions. However
as more data become available on the conditions in the
chicken gut, the model has the potential of being used
in situations relevant to the food industry.
Transposon methods
Flux balance analysis methods have a good track record
of predicting essential genes [16], however, they only
focus on metabolism-related genes. In this study, the
FBA model only contained reactions linked to 388
genes, 24% of the total genome. In vitro transposition
has the advantage of targeting the whole genome. We
describe the construction of two transposon mutant
libraries in C. jejuni NCTC11168 and the mapping of a
t o t a lo f9 5 5 0i n s e r t si nt h eg e n o m e ,t h i sr e p r e s e n t sa
coverage of 5.94× using the method of Stahl and Stintzi
[20]. Data from the combined transposon mutagenesis
libraries predicted 233 essential genes (14% of the gen-
ome total). While FBA only uses a subset of genes from
the genome, the number of predicted essential genes
was similar at 175 (11% of the genome). These numbers
are similar to the published C. jejuni study (194 genes,
12% of the genome) although the overlap between the
published study and the data presented in this study is
comparatively small (only 8 genes predicted by all three
methods). Compared to other published essential gene
prediction studies, the number of predicted essential
genes is between the lower quartile and median with
respect to total number of essential genes and percen-
tage of the genome predicted to be essential. However,
reviewing all published microbial essential gene predic-
tions, we noted there was no correlation between num-
ber of predicted essential genes and genome size (data
not shown). Clearly the relationship between genome
size, complexity of niche, and indispensable genes is
complex, plus a number of caveats should always be
considered when interpreting this sort of data: any gene
containing at least one insert can be said to be non-
essential under the growth conditions described. How-
ever, the inverse logic is not true. The absence of an
insert in a gene does not necessarily mean that the gene
is required for growth and hence essential. Transposon
insertion may not have occurred for a variety of reasons:
chance, sequence bias of the transposase or transposon
depletion during the reaction. Although no detailed stu-
dies of the sequence preference of either transposases
used here have been carried out and it is generally
assumed they are essentially random, we used two dif-
ferent transposases in an attempt to minimise any effect
of sequence bias. An over-representation of small
hypothetical proteins (and accordingly, small genes lack-
ing an insert) may have resulted from the random nat-
ure of the transposon insertion: i.e. the smaller the gene,
the smaller the chance of transposon insertion; however,
no gene size bias was observed when comparing genes
with insert with genes encompassing the entire genome.
T h eg e n o m eo fC. jejuni NCTC 11168 totals
1,641,481 bases and thus our libraries represent inser-
tions in only ~0.006% of the possible positions. It is
possible that the number of inserts identified is an
under representation of the actual total since inserts
close together would generate very similar sized PCR
products that may fail to be discriminated on the agar-
ose gels. Additionally, the abundance of individual
mutants in the isolated pooled genomic DNA may also
affect whether a band is visible. Since the genomic
DNA used was isolated from pooled colonies, it is pos-
sible that any mutant resulting in reduced growth and
hence colony size would be under represented in the
pooled material and as a consequence, would not be
detected. The whole genome in vitro transposition pre-
sented in this study should be seen as a high-through-
put method, as opposed to a high precision method. A
number of caveats should not be ignored: the library
unlikely represents all possible insertion points and
some regions may be naturally more resistant to accept-
ing an insert. Detection is constrained by the primer
library, which in this case was optimized for microarray
probe generation. The PCR and agarose gel-based
approach also suffers from more common technical
drawbacks such as smaller PCR products are more
favourably amplified that longer ones and accuracy of
sizing gel fragments is not infallible. Additionally, polar
effects due to operon structure, may result in the null
recovery of some mutants, if the transcription and
translation of upstream genes is perturbed by a transpo-
son insert, as was shown for the C. jejuni fur gene
which in itself is not essential [58]
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genes
Another source of information which covers a high per-
centage of the genome is the Protein-Protein Interaction
(PPI) network of C. jejuni, obtained by yeast two-hybrid
methods which covers 80% of the proteome [48]. Each
protein is a node and if they interact, they are linked by
an edge. Essential genes have been linked to the topolo-
gical properties of the PPI network, as it has been
shown that essential genes are more likely to be hubs of
the PPI network than by chance [59,60]. We have inves-
tigated whether there is a correlation between the
d e g r e e so ft h en o d e st h eP P In e t w o r ko fC. jejuni and
essential genes determined using FBA and transposon
mutagenesis. No correlation was observed, contrarily to
what was predicted by Parrish et al. [48]. They based
their analysis on putative essential proteins which were
orthologs of Escherichia coli and Bacillus subtillis essen-
tial proteins. However, it has been shown that these bac-
t e r i ad on o ts h a r em a n ye s s e n t i a lg e n e s ,e s p e c i a l l yB.
subtillis [20]. More recent analyses of binary PPI net-
works suggest that the relationship between hubs and
essential proteins is more complex, with hubs being cor-
related to genetic pleiotrophy; that is hubs are proteins
that have many phenotypes when the gene encoding
that protein is deleted [61]. The interpretation of PPI
networks remains ambiguous and models to explain the
universal structure of PPI networks have been proposed
to be related to evolutionary principles such as duplica-
tion and mutation of a few ancestors [62] or to the
potential of proteins to bind together because of their
physical properties, such as binding affinity and folding
[63].
The shikimate pathway
Whilst the genome-wide comparison of gene essentiality
with PPI hubs has not been fruitful in this study, the
shikimate pathway in particular exhibits a large number
of proteins with high degrees (see Figure 4). Since the
interpretation of physical PPI network remains ambigu-
ous, the high degrees of this pathway could be inter-
preted in multiple ways. Nonetheless, the combination
of essential gene prediction methods has drawn focus to
this particular pathway as a potential target for interven-
tion, which should be investigated further using conven-
tional genetic tools. The shikimate pathway has been
the subject of antimicrobial research in previous studies
[21,64,65]. As reported by other groups, the shikimate
pathway is present in bacteria, plants, and fungi, but
absent in humans, making it the target for novel antimi-
crobials and herbicides [21]. More specifically, Zucko et
al. show that a complete shikimate pathway is present
in 76% of 442 bacterial genomes studied, although lar-
gely incomplete in Archaea [66]. Two E. coli studies also
identify essential genes from this pathway: aroH, aroK
were predicted essential by Gerdes et al. [67] and aroB,
aroD, aroE, aroC,a n dpheA plus the entire trpABCDE
operon were predicted essential by Joyce et al. [68]. The
aroD gene is also predicted to be essential in the refined
H. pylori metabolic model [18].
It is noteworthy that without any prior expectations of
pathway targets, the methods presented in this work
point towards a known target pathway for novel antimi-
crobial interventions. However, the ultimate validation
of our approach requires further laboratory investigation
that is beyond the scope of this paper.
Conclusions
We have presented the first curated metabolic model of
the important pathogen Campylobacter jejuni and dis-
cussed insights into the organism’s metabolism. Flux
Balance Analysis used in combination with a transposon
mutagenesis library has been used to make predictions
about essential genes, and these predictions have been
further informed with reference to other published stu-
dies, such as the PPI dataset. This analysis has provided
the basis for further laboratory investigations and sug-
gests a re-evaluation of a previously scrutinized pathway,
which may turn out to be the Achilles heel of this food-
borne pathogen.
Methods
Reconstruction of the metabolic network for FBA
The reconstruction of the metabolic network is based
on the genome sequence of C. jejuni NCTC 11168 [23]
and a recently curated and updated annotation [22].
Where C. jejuni had H. pylori orthologs (they share
about 2/3 of their genome), the reactions were taken
from the H. pylori model iIT341 GSM/GPR [18] with
the same assumptions. The reactions were also checked
against on-line databases [69,70] and also the literature
on C. jejuni. In particular, the reactions for the central
metabolism and respiration were drawn from a recent
review [24]. The conventions for the names of chemicals
and reactions were kept as close as possible to the H.
pylori model ilT341 GSM/GPR. The reactions added to
the model were elementary and charge balanced based
on a neutral intracellular pH. Where possible, the reac-
tions were associated to genes that encode the proteins
which catalyse them, with Boolean relationships. This
means that for reactions catalysed by isozymes or differ-
ent proteins, the “and”, “or” Boolean operations between
the genes was used [71].
Validation test for the model
To check that the model allowed the bacteria to meta-
bolise the expected substrates, it was tested against BIO-
LOG microplates where the respiration of C. jejuni fed
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Page 11 of 14on different carbon source was measured [32], and,
other literature data [37,42,43,72]. Due to the scarcity of
data in the literature, the model could only be tested
with oxygen for respiration.
Prediction of essential genes by FBA
FBA consists of the computation of the possible fluxes, ν,
going through the reactions of the metabolic network at
steady-state. The system of equations is defined by the
stoichiometric matrix, S, containing the stoichiometric
coefficients of the metabolic reactions, with m being the
number of metabolites, and n the number of fluxes [15].
At steady-state (i.e. during balanced growth when the
biomass composition is assumed to be constant), S.ν = 0.
There are more fluxes than metabolites (n >m), so the
system is underdetermined. The fluxes are bound by
thermodynamic feasibility so the space of solutions is a
convex space [15]. It has been shown with some organ-
isms, notably with E. coli [16], that the flux through the
biomass is optimised for the uptake of nutrients during
balanced growth, so the biomass equation can be used as
an objective function to reduce the space of solutions.
With less well characterised micro-organisms like C.
jejuni, the biomass composition is not known quantita-
tively. The biomass composition was assumed to be the
same as for H. pylori except for (a) vitamin B6, which
was added to the equation as the genome is predicted to
encode the entire biosynthetic pathway bar one gene and
(b) thiamine, for which the active form was assumed to
be thiamine diphosphate rather than thiamine.
Exploration of the space of solution: Even after
appointing an objective function, there may be more
than one solution to the optimisation problem. These
solutions are referred to as silent phenotypes as the
growth rate is the same but the internal organisation of
the fluxes is different [73]. Due to the design of the
algorithm, the solution returned by simplex linear pro-
gramming generally minimizes the number of fluxes.
To estimate whether a gene is essential or not, the
ratio, Gr, of the biomass flux when the gene is absent to
the biomass flux when the gene is present was calcu-
lated in a given environment [74]. A gene was consid-
ered essential if Gr <= 10
-9 (arbitrary value).
Medium composition: Minimal medium was used to
validate the model. Its substrates were derived from the
BIOLOG medium experiments http://www.biolog.com.
The experiments to screen for essential genes were car-
ried out in Brucella medium which is a rich medium con-
taining pancreatic digest of casein, peptic digest of animal
tissues, dextrose, yeast extract, sodium chloride and
sodium bisulfite [75]. Since the composition of this med-
ium is unknown, the medium was assumed to be similar
to yeast extract [76], the composition used for simula-
tions is indicated in the table in the Additional file 5:
medium composition. The chemicals are allowed to enter
or leave the system through exchange reactions. The
exchange fluxes of the carbon source were fixed to a
maximum of 20 mmol/g dry weight of biomass/h, which
is close to a maximum uptake rate for E. coli [77] and 5
mmol/g dry weight of biomass/h for oxygen, which is
about a fourth of the maximum fluxes measured in air
for E. coli as C. jejuni is microearophilic. The other nutri-
ents present in the medium were assumed to be non-lim-
iting with an arbitrary uptake higher boundary of 1,000
mmol/g dry weight of biomass/h.
All the calculations related to FBA were carried out
with the COBRA Toolbox [74] in Matlab (version
R2010b, Mathworks, Inc.) equipped with the glpk solver
for linear programming [78].
Transposon mutagenesis
Two in vitro transposition libraries were constructed
using mariner transposase, essentially as described by
Gaskin and van Vliet [79] and Tn7 transposase from
New England Biolabs with C. jejuni NCTC11168 geno-
mic DNA. These were introduced into C. jejuni NCTC
11168 cells by natural transformation [79] and plated
onto Blood Agar Base no.2 (Oxoid) plates supplemented
with 5% v/v defribinated horse blood and kanamycin 50
μg/ml. After ~48 hours incubation at 42°C under micro-
aerophilic conditions (5% oxygen, 10% carbon dioxide,
85% nitrogen) colonies were pooled and genomic DNA
extracted using QIAgen genomic-tips (QIAgen).
Mapping of transposon insertions
Genomic DNA from the pooled colonies was used as
template in polymerase chain reactions using a transpo-
son specific primer and individual gene specific primers.
Briefly, 50 μl reactions were set up using 100 ng geno-
mic DNA, 10-50 pmol of each primer and 25 μl of Hot-
StarTaq mix (QIAgen). Cycling conditions were 95°C
f o r1 5m i n ,f o l l o w e db y3 0c y c l e so f9 5 ° C3 0s e c ,5 0 ° C
30 sec, 72°C 90 sec and a final 72°C 15 min extension
step. Aliquots from each reaction were run on 0.8%
agarose gels, which were stained with ethidium bromide.
Gel images were captured using a GeneDoc system
(Anachem). The sizes of observed bands were calculated
using Labimage (Kapelan Bio-Imaging GmbH) and this
data was inputted into Excel (Microsoft). Based on the
transposon study, 47 insertional inactivation mutants
were created using conventional methods to validate the
Tn7/Mariner findings.
Additional material
Additional file 1: Tables with the reactions included in the model,
the metabolites and the references use to reconstruct the model.I n
the reaction table, the EC numbers of the reactions are indicated as well
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Page 12 of 14as the H. pylori orthologs as appropriate. The reactions are associated to
genes with Boolean rules. The reactions were categorised in pathways
similarly to the model of H. pylori.
Additional file 2: This table shows the substrates that were
predicted to be metabolised according to the proposed model and
compared to experimental data from the literature.
Additional file 3: This table shows whether genes were predicted to
be dispensable by different methods: FBA predictions, number of
inserts of the transposon mutagenesis for the two transposon
libraries of this study and whether inserts were present in the
transposon mutagenesis of an independent study [20]. The degrees
of the protein in the PPI network and known mutants are also indicated.
Additional file 4: This table is a list of the proteins encoded by
genes without a transposon insert as determined in this study
(putative essential genes), classified according to the KEGG, BioCyc,
and JCVI databases.
Additional file 5: Table of substrates allowed in the system to
determine essential genes in silico.
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